Chauncey Billups, the head coach of the Portland Trail Blazers, is in the spotlight for all the wrong reasons. He's been linked to a scheme where the team allegedly planned to throw a game in March 2023 against the Chicago Bulls. This wasn't just any game; it was a strategic move to boost their chan
Biotech stocks have had a rough time since their peak in early 2021. They didn't join the market's rebound in 2022, but this summer brought a change. These stocks are tricky because most of them are in the early stages of development. They often don't have earnings or steady revenue, relying instead
Hamilton Stock has been making waves in the insurance sector. It's not just any company; it's a leader in its field. Recently, it has entered a new buy zone. This means it might be a good time to consider investing in it. But why is this significant? Well, the insurance industry is huge. It's all a
Next year, seniors and other Social Security beneficiaries will see a small boost in their monthly checks. The increase is 2. 8%, which works out to about $56 more per month for the average person. This change is meant to help with rising costs, but it might not be enough. Health care costs eat up
Baker Hughes is banking on artificial intelligence to drive its future growth. The company is so confident in this tech that it expects to hit $1. 5 billion in data center orders sooner than planned. This is a big deal because it shows how much demand there is for data center power. But it's not al
AXS, a big name in ticketing and event tech, has just welcomed two new leaders to its team. Nikhil Bobde is now the chief tech officer, and Alex Hazboun is stepping into a new role as the chief innovation officer. These changes show that AXS is serious about improving its tech and growing bigger. B
CDR404, a new type of cancer treatment, is making waves in the medical world. This treatment is designed to target specific cancer cells and activate the body's immune system to fight them. Recent studies have shown that CDR404 can trigger a strong immune response in patients with certain types of c
Zymeworks, a biotech company, has shared positive early results from its phase 1 trial. The trial is for a new drug called ZW-191. This drug is designed to target a specific marker called folate receptor-alpha (FRα) found in many cancer types. The results show that ZW-191 can shrink tumors and is ge
Investing in renewable energy can be a bumpy ride. The ups and downs can be tough on investors. So, what can they do to protect their money? They need safe-haven assets. These are investments that can help reduce risk. Think of them as a shield. Gold and green bonds are strong shields. They can pro
Bitcoin's reputation for wild price swings is far from over. Tom Lee, a well-known figure in the crypto world, recently shared his thoughts on the matter. He believes that even with more investors and new financial products, Bitcoin can still drop by half its value. Lee pointed out that Bitcoin oft
